Virbac SA

Common Name
Virbac
Country
France
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
5,386
Ticker
VIRP
Exchange
EURONEXT
Description
Virbac S.A. is a leading pharmaceutical company dedicated exclusively to animal health. Established in 1968 by French veterinarian Pierre-Richard Dick, the company has built a global presence, serving...

Virbac's GHG Emissions Data Preview

In 2024, Virbac completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Virbac has also provided a category-level breakdown for 9 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind Virbac’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Virbac’s data sources below and access millions more through our Disclosure Search.

a. Virbac's Sustainability Report 2024
a. Virbac's Sustainability Report 2024
b. Virbac's Non-financial report 2023
b. Virbac's Non-financial report 2023

Insights into Virbac's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Virbac amounted to 29,902 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Virbac increased by ∞%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

Virbac's Scope 1 Emissions Over Time

202403 k6 k9 k12 ktCO2e
  • Total Scope 1
  • Year-over-Year Change

What are Virbac's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Virbac were 10,966 metric tons of CO₂ equivalent (tCO₂e). a

What are Virbac's Scope 2 emissions?

In 2024, Virbac reported Scope 2 greenhouse gas (GHG) emissions of 19,311 tCO₂e using the market-based method and 18,936 tCO₂e using the location-based method. a

What methodology does Virbac use for Scope 2 reporting?

In 2024, Virbac reported its Scope 2 emissions using the market-based method and using the location-based method. a

Virbac's Scope 2 Emissions Over Time

202405 k10 k15 k20 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Virbac's Value Chain Emissions

In 2024, Virbac reported 471,597 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2024 disclosure of Virbac includes a breakdown across 9 of the 15 Scope 3 categories defined by the GHG Protocol, up from 1 in 2023, reflecting improved emissions accounting practices and greater transparency across the company's value chain a

Virbac's Scope 3 Emissions Over Time

20212022202320240150 k300 k450 k600 ktCO2e-8%-19%+5580%
  • Total Scope 3
  • Year-over-Year Change

What are Virbac's Scope 3 emissions?

In 2024, Virbac reported total Scope 3 emissions of 471,597 metric tons of CO₂ equivalent (tCO₂e). a

Approximately 95.33% of these emissions originated from upstream activities such as purchased goods and capital goods, while 4.67% came from downstream activities like product use, distribution, and end-of-life treatment. a

Has Virbac reduced its Scope 3 emissions over time?

Since 2021, Virbac's Scope 3 emissions have increased by 4,151.3%, reflecting a rising long-term trend in Scope 3 emissions over time. a b

Compared to the previous year (2023), Virbac's Scope 3 emissions increased by 5,579.84%, suggesting that the company faced challenges in reducing emissions across its value chain. a b

What categories of Scope 3 emissions does Virbac disclose?

In 2024, Virbac reported emissions for 9 out of the 15 Scope 3 categories defined by the GHG Protocol. a

This partial disclosure allows for some insight into the company's indirect impacts.

What are the main sources of Virbac's Scope 3 emissions?

In 2024, the largest contributors to Virbac's Scope 3 emissions were: a

  • Purchased Goods and Services (Cat. 1): 231,765 tCO₂e (49.14%)
  • Upstream Transportation and Distribution (Cat. 4): 187,757 tCO₂e (39.81%)
  • End-of-Life Treatment of Sold Products (Cat. 12): 22,046 tCO₂e (4.67%)

Virbac's Scope 3 Emissions by Categories

Purchased Goods andServices (Cat. 1)(49.1%)End-of-LifeTreatment of SoldProducts (Cat. 12)(4.7%)UpstreamTransportation andDistribution(Cat. 4)(39.8%)

Insights into Virbac’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Virbac reported Scope 1 greenhouse gas (GHG) emissions of 10,966 tCO₂e and total revenues of USD 1,454 millions. This translates into an emissions intensity of 7.54 tCO₂e per millions USD. a

Virbac's Scope 1 Emissions Intensity Compared to Peers

5005,00050,0001,000,00010,000,000Scope 1 Emissions (tCO2e)1005005,00020,000200,000Revenues (Millions of USD)ZCTOSanofiYear: 2024Scope 1: 298,485 tCO2eRevenue: $M 46,085Scope 1 Intensity: 6.48 tCO2e/$MNovo NordiskYear: 2024Scope 1: 85,000 tCO2eRevenue: $M 40,472Scope 1 Intensity: 2.10 tCO2e/$MJCR PharmaceuticalsYear: 2022Scope 1: 3,315 tCO2eRevenue: $M 419Scope 1 Intensity: 7.92 tCO2e/$MGilead SciencesYear: 2024Scope 1: 53,856 tCO2eRevenue: $M 28,754Scope 1 Intensity: 1.87 tCO2e/$MCosmo PharmaceuticalsYear: 2024Scope 1: 5,658 tCO2eRevenue: $M 260Scope 1 Intensity: 21.74 tCO2e/$MSanten PharmaceuticalYear: 2024Scope 1: 17,372 tCO2eRevenue: $M 1,994Scope 1 Intensity: 8.71 tCO2e/$MBiogenYear: 2024Scope 1: 56,611 tCO2eRevenue: $M 9,676Scope 1 Intensity: 5.85 tCO2e/$MOno PharmaceuticalYear: 2024Scope 1: 8,100 tCO2eRevenue: $M 3,319Scope 1 Intensity: 2.44 tCO2e/$MKalbe FarmaYear: 2024Scope 1: 19,895 tCO2eRevenue: $M 2,028Scope 1 Intensity: 9.81 tCO2e/$MZZZhangzhou Pientzehuang PharmaceuticalYear: 2023Scope 1: 2,301 tCO2eRevenue: $M 1,415Scope 1 Intensity: 1.63 tCO2e/$MPfizerYear: 2024Scope 1: 613,218 tCO2eRevenue: $M 63,627Scope 1 Intensity: 9.64 tCO2e/$MChugai PharmaceuticalYear: 2024Scope 1: 51,143 tCO2eRevenue: $M 7,456Scope 1 Intensity: 6.86 tCO2e/$MOtsuka HoldingsYear: 2021Scope 1: 1,030,000 tCO2eRevenue: $M 13,021Scope 1 Intensity: 79.10 tCO2e/$MAmgenYear: 2024Scope 1: 147,000 tCO2eRevenue: $M 33,424Scope 1 Intensity: 4.40 tCO2e/$MAstellas PharmaYear: 2023Scope 1: 59,203 tCO2eRevenue: $M 11,401Scope 1 Intensity: 5.19 tCO2e/$MJiangsu Hengrui PharmaceuticalsYear: 2024Scope 1: 8,517 tCO2eRevenue: $M 3,835Scope 1 Intensity: 2.22 tCO2e/$MOrganon & CoYear: 2024Scope 1: 34,200 tCO2eRevenue: $M 6,403Scope 1 Intensity: 5.34 tCO2e/$MCCCSPC Pharmaceutical GroupYear: 2024Scope 1: 474,567 tCO2eRevenue: $M 4,327Scope 1 Intensity: 109.67 tCO2e/$MRoche HoldingYear: 2024Scope 1: 245,832 tCO2eRevenue: $M 68,903Scope 1 Intensity: 3.57 tCO2e/$MMerck & Co IncYear: 2024Scope 1: 721,200 tCO2eRevenue: $M 64,168Scope 1 Intensity: 11.24 tCO2e/$MRecordatiYear: 2024Scope 1: 37,280 tCO2eRevenue: $M 2,437Scope 1 Intensity: 15.30 tCO2e/$MSichuan Kelun PharmaceuticalYear: 2024Scope 1: 2,361,763 tCO2eRevenue: $M 2,989Scope 1 Intensity: 790.21 tCO2e/$MTTTong Ren Tang TechnologiesYear: 2024Scope 1: 30,000 tCO2eRevenue: $M 1,086Scope 1 Intensity: 27.62 tCO2e/$MKyowa KirinYear: 2024Scope 1: 16,133 tCO2eRevenue: $M 3,157Scope 1 Intensity: 5.11 tCO2e/$MOOOrion OyjYear: 2024Scope 1: 5,625 tCO2eRevenue: $M 1,605Scope 1 Intensity: 3.50 tCO2e/$MVirbacYear: 2024Scope 1: 10,966 tCO2eRevenue: $M 1,454Scope 1 Intensity: 7.54 tCO2e/$M

How does Virbac's GHG emissions intensity compare to its peers?

In 2024, Virbac reported a Scope 1 emissions intensity of 7.54 tCO₂e per millions USD. Compared to the peer group median of 6.48 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a

Where does Virbac rank on GHG emissions intensity within its industry?

In 2024, Virbac ranked 15 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Virbac is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Insights into Virbac's Total Carbon Footprint

In 2024, Virbac reported a total carbon footprint of 501,499 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 5,939.97% increase compared to 2023, suggesting a rise in emissions across its operations or value chain. a b

The largest contributor to Virbac's total carbon footprint was Scope 3 emissions, accounting for 94.04% of the company's total carbon footprint, followed by Scope 2 emissions at 3.78%. a

Want Full Access to Virbac's GHG Emissions Dataset?
Sign Up